A tissue targeting complex comprising a tissue targeting moiety an octadentate hydroxypyridinone containing ligand comprising four HOPO moieties and the ion of an alpha emitting thorium radionuclide where at least one of the four HOPO moieties is substituted at the N position with a hydroxyalkyl solubilising group.